Tandem Diabetes Care (TNDM) announced the appointment of Jean-Claude Kyrillos as Executive Vice President, EVP, and Chief Operating Officer, COO, effective June 21, 2024. Kyrillos comes to Tandem with more than 20 years of global executive leadership experience in medical device, digital health, and healthcare management. Kyrillos previously served in operating company president roles at Envista (NVST) from February 2020 to June 2023, most recently as President of Diagnostics and Digital Solutions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes extends development agreement with DexCom
- Tandem Diabetes price target raised to $58 from $47 at Oppenheimer
- Tandem Diabetes’ (NASDAQ:TNDM) Stock Surges, But Faces fierce Competition
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Tandem Diabetes initiated with a Buy at Redburn Atlantic